BusinessMRI Interventions’ ClearPoint® Neuro Navigation System to be Utilized in Medicenna Therapeutics’ Phase 2 MDNA55 Clinical Trial for the Treatment of Recurrent GlioblastomaBy Nasdaq OMXDec 19, 2016, 2:00 PM UTC
BusinessMRI Interventions’ ClearPoint® Neuro Navigation System Utilized in Voyager Therapeutics’ VY-AADC01 Phase 1b Trial; Positive Interim Results ReportedBy Nasdaq OMXDec 8, 2016, 2:00 PM UTC
BusinessMRI Interventions’ ClearPoint® Neuro Navigation System to be Exhibited at Pediatric Neurosurgical ConferenceBy Nasdaq OMXDec 5, 2016, 2:00 PM UTC
BusinessMRI Interventions’ ClearPoint® Neuro Navigation System to be Featured at the American Epilepsy Society MeetingBy Nasdaq OMXNov 28, 2016, 11:00 AM UTC
BusinessMRI Interventions, Inc. Announces 2016 Third Quarter and Nine Month ResultsBy Nasdaq OMXNov 4, 2016, 1:00 PM UTC
BusinessMRI Interventions, Inc. Announces Fiscal 2016 Third Quarter Financial Results Conference Call and WebcastBy Nasdaq OMXNov 2, 2016, 2:40 PM UTC
BusinessMRI Interventions and Texas Biomedical Research Institute Demonstrate Precise Delivery and Increased Viability of Neural Stem Cell Transplantation Utilizing the ClearPoint® Neuro-Navigation SystemBy Nasdaq OMXOct 21, 2016, 1:01 PM UTC
BusinessUniversity of Pittsburgh Medical Center (UPMC) Completes its 75th MRI Guided Procedure With MRI Interventions’ ClearPoint® Neuro-Navigation SystemBy Nasdaq OMXOct 17, 2016, 1:00 PM UTC
